Notarius CF, Morris BL, Floras JS. Dissociation between reflex sympathetic and forearm vascular responses to lower body negative pressure in heart failure patients with coronary artery disease. Am J Physiol Heart Circ Physiol 297: H1760 -H1766, 2009. First published September 4, 2009 doi:10.1152/ajpheart.00012.2009.-Many heart failure (HF) patients exhibit paradoxical forearm vasodilation when central blood volume is reduced by lower body negative pressure (LBNP). We tested the hypothesis that this response results from reflex sympathetic withdrawal. We recorded simultaneously forearm blood flow, muscle sympathetic nerve activity (MSNA), and plasma norepinephrine (PNE) during four random applications of LBNP, Ϫ5, Ϫ10, Ϫ20, and Ϫ40 mmHg, in 12 men with HF (mean left ventricular ejection fraction ϭ 24 Ϯ 2%) and 10 healthy, normal, age-matched men (N). Compared with N, MSNA burst frequency (P ϭ 0.001) and PNE (P ϭ 0.005) were significantly higher in the HF group, both at rest and during LBNP. As anticipated in N, LBNP Ϫ40 mmHg significantly increased MSNA (ϩ14.2 Ϯ 2.5 bursts/min; P Ͻ 0.05) and PNE (ϩ0.83 Ϯ 0.22 nmol/l; P Ͻ 0.05) and decreased forearm vascular conductance (FVC) (Ϫ11.7 Ϯ 3.2 ml ⅐ min Ϫ1 ⅐ mmHg Ϫ1 ; P Ͻ 0.05). In the HF group, LBNP elicited similar increases in MSNA (ϩ11.5 Ϯ 2.0; P Ͻ 0.05) and PNE (ϩ0.85 Ϯ 0.12; P Ͻ 0.05), without affecting FVC significantly (Ϫ4.1 Ϯ 2.4; P ϭ 0.01 vs. N, interaction P ϭ 0.03). However, within the HF group, responses were bimodal: LBNP Ϫ40 mmHg increased MSNA in all subjects (P Ͻ 0.001), yet the six patients with nonischemic or dilated cardiomyopathy (DCM) exhibited significant vasoconstriction (decrease in FVC; P ϭ 0.001), whereas the six patients with ischemic cardiomyopathy (ICM) exhibited significant vasodilation (increase in FVC; P Ͻ 0.02 vs. DCM and N; interaction P ϭ 0.02). Cold pressor testing increased MSNA and decreased FVC in ICM (n ϭ 4). Thus paradoxical forearm vasodilator responses to LBNP in HF are not mediated by reflex sympathetic withdrawal. ICM and DCM patients differ qualitatively in their vascular responses to hypotensive LBNP. etiology; microneurography; muscle sympathetic nerve activity; vascular conductance BEFORE THE DEVELOPMENT OF assays for quantifying plasma catecholamines,
BEFORE THE DEVELOPMENT OF assays for quantifying plasma catecholamines, or the introduction of direct microneurographic recordings of muscle sympathetic nerve activity (MSNA), the contribution of the sympathetic nervous system to cardiovascular regulation in conscious humans often was assessed indirectly by evaluating responses mediated by reflex sympathetic activation, such as changes in forearm vascular conductance (FVC), in response to acute displacement of blood volume into the legs. Although orthostatic stimuli, such as tilt, or graded lower body negative pressure (LBNP) elicited, consistently, forearm vasoconstriction in healthy subjects (9, 34, 36, 38) , this response was not augmented, as had been anticipated, in patients with heart failure (HF) due to ventricular systolic dysfunction (8, 14, 22, (25) (26) (27) 37) . Rather, many investigators observed either marked attenuation of forearm vasoconstriction, or paradoxical forearm vasodilation (14, 26, 27) . Such findings were attributed to either altered cardiopulmonary baroreflex regulation of vascular resistance, resulting in attenuated reflex sympathetic vasoconstriction, or, in some instances, a paradoxical reflex sympathetic withdrawal (10, 11, 26) , or to release of epinephrine as a cotransmitter with norepinephrine in HF (12, 21) with subsequent ␤ 2 -adrenoceptor-related vasodilation (23) .
Sympathetic activation in HF arises from loss of inhibitory, and activation of excitatory, baroreflex-and nonbaroreflex-mediated regulatory mechanisms (16, 17) . In humans, the main defect in baroreceptor regulation of the sympathetic nervous system appears to arise from reflexes originating in mechanoreceptors situated within the heart and pulmonary vasculature (3, 11) . However, whether such impairment results in muscle sympathetic withdrawal and, as a consequence, paradoxical forearm vasodilation has not been evaluated by simultaneous measurement of these variables. Moreover, the previous literature investigation of this theme has comprised, almost exclusively, patients whose systolic dysfunction was of ischemic origin (8, 10, 14, 22, 23, 25, 26) . Also, such observations often arose from experiments in untreated HF patients, or in patients studied before the introduction of contemporary treatment for HF. Whereas, in the past, sympathetic neural activation was considered a hallmark of chronic HF due to systolic dysfunction, it is now appreciated that, in current practice, many such patients do not exhibit sympathetic activation, but, once this develops, its consequences include increasing congestion, symptoms such as diminished exercise capacity, and increased probability of premature mortality due to accelerated disease progression or sudden death (4, 7, 16, 28) .
Recently, we reported higher MSNA at rest in HF patients with coronary artery disease than in patients matched for ejection fraction but without coronary artery disease (30 We conducted the present experiments to test two specific hypotheses: 1) attenuated vasoconstriction and/or paradoxical vasodilation in response to LBNP in HF patients results from blunted sympathetic excitation and/or paradoxical sympathetic withdrawal; and 2) patients with left ventricular systolic dysfunction and coronary artery disease are more likely to exhibit such paradoxical vasodilation.
METHODS

Subjects
HF patients. We studied 12 men (age 55 Ϯ 3 yr; mean Ϯ SE) with stable moderate to severe impairment of left ventricular function (ejection fraction by radionuclide ventriculography, 24 Ϯ 2%). Of these, 10 (83%) were receiving ␤-adenoceptor antagonists, 11 (92%) angiotensin-converting enzyme inhibitors, 6 (50%) digitalis, 11 (92%) diuretics, 4 (33%) anticoagulants, and 4 (33%) statins. On the basis of medical history and coronary angiography, six men were classified as having HF due to coronary artery disease, and six were considered to have nonischemic DCM. No patient had a change in medical therapy or a hospitalization for cardiovascular causes over the prior 3 mo, and none had suffered a myocardial infarction or undergone coronary revascularization in the preceding 6 mo. Additional exclusion criteria were diabetes, symptomatic angina, valvular heart disease, moderate or severe hypertension [blood pressure (BP) Ͼ 170/105 mmHg], hypertensive heart disease, HF due to myocarditis, infiltrative or postpartum cardiomyopathy, or any significant intercurrent illness.
Normal subjects. Ten heathy male volunteers were screened by medical history. None were taking medication. Their mean age was 48 Ϯ 2 yr.
The protocol was approved by the Ethics Committee of the University Health Network, and informed consent was obtained from all subjects before participation.
Procedures
Preparation. Diuretics were withheld on the morning of each microneurographic study to avoid the sympathoexcitatory effect of a full bladder (13) . Subjects were placed supine in a metal LBNP chamber. In 6 of the 12 HF subjects, a catheter for measurement of central venous pressure (19 gauge, 24- Values are means Ϯ SE; n, no. of subjects. LV, left ventricular; FBF, forearm blood flow; FVR, forearm vascular resistance; FVC, forearm vascular conductance; MSNA, muscle sympathetic nerve activity; PNE, plasma norepinephrine; V O2peak, peak oxygen uptake. *Statistical difference: normal subjects vs. heart failure patients. †n ϭ 9 and n ϭ 11, respectively. Values are means Ϯ SE; n, no. of subjects. LBNP-5, LBNP-10, LBNP-20, LBNP-40: lower body negative pressure at 5, 10, 20, and 40 mmHg, respectively; HF, heart failure; SBP, systolic blood pressure; DBP, diastolic blood pressure; MAP, mean arterial blood pressure; PE, plasma epinephrine. *P Ͻ 0.05 vs. baseline within groups.
toward the right atrium. Venous blood was sampled from this line during the last 2 min of each LBNP level and submitted to plasma norepinephrine and epinephrine determination by high-performance liquid chromatography (15) . Because of subject preference, in the remaining 6 HF patients and all 10 healthy, normal (N) subjects, blood instead was sampled from an antecubital venous catheter. BP was monitored every minute by an automated device (Dinamap Pro 100; Critikon LLC, Tampa, FL), and heart rate was derived from lead II of the electrocardiogram. Mean arterial pressure was calculated as onethird pulse pressure ϩ diastolic BP.
Multiunit recordings of postganglionic MSNA were obtained with a unipolar tungsten electrode inserted selectively into a muscle-nerve fascicle of the right or left peroneal (fibular) nerve, posterior to the fibular head, as described previously (28, 29) . Sympathetic nerve bursts were counted using customized computer analysis (LabVIEW software, National Instruments, Austin, TX) and expressed as burst frequency (bursts/min) and burst incidence (bursts/100 heart beats).
Forearm blood flow (FBF) was measured by plethysmography with a mercury-in-Silastic strain-gauge apparatus (model 270A, Parks Electronics Laboratory, Beaverton, OR, or EC6 plethysmograph, or D. E. Holkanson Bellevue, WA) (40) . The strain gauge was placed ϳ5 cm below the antecubital crease of the nondominant arm. The arm was elevated and supported so that the proximal forearm was ϳ10 cm above the anterior chest wall. Circulation to the hand was arrested by inflation of the wrist cuff to 180 -200 mmHg during measurement of blood flow. The pressure in the venous occlusion cuff on the upper arm was 40 mmHg. FBF (in ml ⅐ 100 g Ϫ1 ⅐ min Ϫ1 ) was calculated from the mean of four to eight measurements made at 15-s intervals over 2 min. Forearm vascular resistance (FVR) was calculated as follows: FVR ϭ mean arterial pressure/FBF. FVC was calculated as the reciprocal of FVR.
Signals were output to a recorder (Gould Viper-TA, Gould Instrument Systems, Madison, WI) and, following analog-to-digital conversion, stored in a personal computer for subsequent analysis.
Protocol
After this setup and following a stabilization period, a 7-min baseline recording, including 2 min of FBF, was acquired. Thereafter, the following three interventions and four LBNP levels were imposed in random order, with each maneuver separated by 10 min blocks.
LBNP. Four minutes each of intermittent LBNP at Ϫ5, Ϫ10, Ϫ20, and Ϫ40 mmHg were applied. Responses over the last 2 min of each level were averaged.
Cold pressor test. The right hand was immersed in ice water for 90 s, in a subgroup of nine HF and six healthy subjects, to ensure that sympathetically mediated vasoconstriction elicited by a nonbaroreceptor reflex stimulus to neural norepinephrine release did not differ between groups.
Reactive hyperemia. To ensure that vasodilator capacity did not differ between groups, the immediate vascular response to hyperemia was assessed in nine HF and seven of the control subjects. An upper arm cuff was inflated to suprasystolic levels (Ͻ200 mmHg) for 5 min to provide an ischemic stimulus. The vasodilator reserve was determined by calculating FBF over the first 15-s sequence acquired immediately after release of the cuff (31) .
Exercise tolerance test. Exercise capacity was assessed on a separate day by a graded exercise test performed on a bicycle ergometer with ramped increments of 17 W/min until pedal speed could no longer be maintained and the respiratory exchange ratio (CO 2 production/O2 consumption) exceeded 1.1. Oxygen consumption at peak exercise (V O2peak) was obtained by open circuit spirometry (Horizon MMC System or Vmax Series 229, Sensormedics, CA). V O2peak was expressed both as liters per minute, milliliters per kilogram per minute, and as percentage of predicted V O2peak, to account for age, sex, body weight, and height. Change in muscle sympathetic nerve activity (MSNA) burst frequency (top) and forearm vascular conductance (FVC; bottom) with LBNP in HF patients (F) and healthy normal (N) subjects (E). Both groups had similar increase in MSNA burst frequency (main effect LBNP, P Ͻ 0.001), but, in HF patients, the fall in FVC during LBNP was less than in healthy N subjects (main effect LBNP, P ϭ 0.007; interaction, P ϭ 0.03). *P Ͻ 0.05 between groups; #P Ͻ 0.05 vs. LBNP Ϫ5 mmHg.
Statistical Analysis
Data are presented as means Ϯ SE. Unpaired t-tests were performed to test for differences between group means for dependent variables measured at rest. A repeated-measures two-way ANOVA was used to examine the main effects of group (HF, N) and LBNP (Ϫ5, Ϫ10, Ϫ20, Ϫ40 mmHg) or cold pressor test (CPT) (SigmaStat for Windows, version 1.0, Jandel Scientific, San Rafael, CA) on dependent variables. A similar analysis was applied to assess differences in response between HF etiology groups (ischemic, nonischemic) and N subjects. Prespecified hypotheses were then assessed by the post hoc Student Newman-Keuls test.
RESULTS
Descriptive and Resting Data
See Table 1 . Cohorts were well matched for age, body weight, and height. Both absolute and normalized V O 2peak were significantly reduced in the HF patients (P Ͻ 0.001), with a mean V O 2peak in patients at 63% of predicted vs. 95% of predicted in N subjects. Resting heart rate, BP, FBF, and calculated FVR and FVC were similar in the two groups. As anticipated, HF patients exhibited significantly higher MSNA (burst frequency and incidence) (P Ͻ 0.001) and plasma norepinephrine (P ϭ 0.009). Venous pressure in six HF subjects with indwelling central catheters was 4.8 Ϯ 0.7 mmHg.
Response to LBNP
See Table 2 . Graded LBNP produced an incremental decline in central venous pressure (Fig. 1) . Heart rate rose significantly in both groups (main effect P Ͻ 0.001). There was a significant increase in heart rate from baseline at an LBNP of Ϫ40 mmHg in N subjects and at both Ϫ20 and Ϫ40 mmHg in the HF group (interaction of group and LBNP, P Ͻ 0.001) ( Table 2) .
BP was stable throughout LBNP in all subjects until LBNP Ϫ40 mmHg, which elicited a slight but significant drop in systolic BP in both groups (main effect, P ϭ 0.009). MSNA burst frequency and incidence were higher in the HF patients at all LBNP levels (main effect of group, P Ͻ 0.001). Importantly, the two subject groups had similar increases in MSNA with LBNP, whether expressed as absolute change in burst frequency from baseline (main effect of LBNP, P Ͻ 0.001; no group effect or interaction) (Fig. 2) , or as the absolute change in burst incidence (P ϭ 0.004, data not shown).
LBNP lowered FBF and FVC significantly in both groups (main effect, LBNP, P ϭ 0.003 and 0.01, respectively, no group effect), but the absolute decrease in FVC was greater in the N subjects. There was virtually no change in FVC in the HF group (interaction, P ϭ 0.03, P ϭ 0.01, HF vs. N at LBNP Ϫ40 mmHg) (Fig. 2) . Thus the principal difference between HF and control subjects was this dissociation between the effect of LBNP on sympathetic vasoconstrictor tone and FVC in the HF group.
HF Etiology
When the FVC response to LBNP Ϫ40 mmHg was examined in individual patients, two distinct patterns emerged: vasoconstriction similar to that in healthy controls in six of the HF patients, but, in the other six, either no change or an increase in FBF and FVC. Vasodilation in these individuals occurred, despite a simultaneous increase in sympathetic vasoconstrictor burst frequency. Figure 3 illustrates this finding in one HF patient. Importantly, this dissociation was only present in the six patients with HF and coronary artery disease.
LBNP elicited similar increases in MSNA burst frequency in HF patients, with or without initial coronary artery disease, and in age-matched N subjects (main effect LBNP, P Ͻ 0.001, no group effect). FVC decreased in the six patients without coronary artery disease and increased only in the six patients with HF and coronary artery disease (interaction P ϭ 0.02). The response to LBNP Ϫ40 mmHg was significantly greater in the latter group than in either patients with nonischemic cardiomyopathy (P ϭ 0.002) or N subjects (P ϭ 0.02) (Fig. 4) .
CPT
In response to the CPT, MSNA increased to a similar extent in HF and N subjects (HF: 47 Ϯ 4.8 bursts/min at rest to 55 Ϯ 5.9 bursts/min during 1.5 min of hand immersion in cold water vs. N: 32 Ϯ 2.2 to 42 Ϯ 5.2 bursts/min; means Ϯ SE, no group main effect), indicating similar capacity of a nonbaroreflex stimulus to increase sympathetic outflow to the peripheral vasculature. However, patients with HF and coronary artery Fig. 3 . Demonstration of paradoxical vasodilation in a HF patient during LBNP Ϫ40 mmHg. The top trace is used to calculate forearm blood flow (FBF) from the rate of rise of forearm volume when venous outflow is occluded. Note the increased slope during LBNP Ϫ40 mmHg (right) compared with baseline (left), which is consistent with a paradoxical vasodilatory response. Mean heart rate (HR) and electrocardiogram (ECG) are also shown. The bottom trace is the mean voltage neurogram from which MSNA is derived. Note the increase in sympathetic nerve bursts per minute during LBNP Ϫ40 mmHg compared with baseline. disease had significantly greater sympathoexcitation than those patients with nonischemic etiology (ICM: 52.7 Ϯ 9.6 bursts/ min at rest to 63.4.9 Ϯ 11.5 bursts/min during CPT; P Ͻ 0.02, vs. DCM: 42.2 Ϯ 4.0 to 48.0 Ϯ 4.4 bursts/min; means Ϯ SE, P ϭ 0.12). There was a significant increase in mean arterial pressure in the ICM group compared with the non-ischemic HF group (P ϭ 0.04), and FVC decreased in all four HF patients with coronary artery disease who performed this test, although this was not statistically significant (from 30.4 Ϯ 3.0 to 22.8 Ϯ 3.0 ml⅐min Ϫ1 ⅐mmHg Ϫ1 , P ϭ 0.09).
Reactive Hyperemic Response
HF and N subjects exhibited similar increases in maximal FBF following 5 min of ischemia (HF: 2.7 Ϯ 0.3 ml ⅐100 g Ϫ1 ⅐min Ϫ1 at rest to 18.6 Ϯ 3.5 ml ⅐100 g Ϫ1 ⅐min Ϫ1 after ischemia vs. N: 2.9 Ϯ 0.2 to 17.4 Ϯ 2.2 ml ⅐100 g Ϫ1 ⅐min
Ϫ1
; means Ϯ SE, no group main effect). However, the patients with HF with ischemic etiology had a significantly greater hyperemic response than those patients without (ICM: 2.5 Ϯ 0.3 ml ⅐100 g Ϫ1 ⅐min Ϫ1 at rest to 23.9 Ϯ 4.6 ml ⅐100 g Ϫ1 ⅐min
after ischemia vs. DCM 2.9 Ϯ 0.6 to 13.2 Ϯ 1.6 ml ⅐100 g Ϫ1 ⅐min Ϫ1 ; means Ϯ SE, P ϭ 0.01).
DISCUSSION
The present study confirms previous reports of an attenuated forearm vasoconstrictor response to LBNP in patients with HF (2, 8, 14, (25) (26) (27) 37 ) and presents two novel findings concerning its interpretation: 1) it cannot be attributed to blunted reflex sympathetic vasoconstriction, refuting previous assumptions; and 2) HF patients with coronary artery disease and HF without coronary artery disease differ qualitatively in their forearm vascular response to this stimulus.
Response to LBNP
In healthy subjects, reduction in central venous pressure caused by graded LBNP elicits reflex increases in MSNA burst frequency in both arm and leg, total body norepinephrine spillover (3, 9, 17, 36, 38) , and FVR (34, 41) . These responses are affected by increased age (9, 34) and deconditioning (35) , which are common features of HF patients.
Previous investigations using changes in plasma norepinephrine concentrations as a surrogate for neurogenic vasoconstriction have attributed the attenuated vascular response to LBNP in HF to less reflex sympathoexcitation, or even sympathetic inhibition (10, 24, 26, 27) . However, because variations in norepinephrine concentrations are a function of changes in regional norepinephrine release, its reuptake, and its clearance (18) , reflex increases in cardiac output augmenting clearance could also decrease plasma norepinephrine concentration in HF patients. A normal increase in MSNA during LBNP (Fig. 2) , even in those patients exhibiting paradoxical vasodilation (Figs. 3 and 4) argues against sympathoinhibition as an explanation for impaired reflex vasoconstriction. Any differences between healthy and HF patients in either central or left ventricular reflex-related sympathetic inhibition during volume unloading (39) , or in stimulation of vagally mediated left ventricular mechanoreceptors by a shift in the left ventricular pressure-volume curve (2, 14) , should elicit comparable differences between groups in directly measured sympathetic nerve traffic, but this was not found. In the present series, muscle sympathetic nerve firing rate rose to a similar extent in both HF and control subjects, yet the reflex forearm vasoconstriction response to LBNP was attenuated markedly in the former group.
Within the HF group, responses were bimodal. Our previously reported finding of higher MSNA at rest in ICM patients (30) suggested that this distribution might be a function of HF etiology. Despite an increase in MSNA during LBNP Ϫ40 mmHg in all subjects, the six patients with nonischemic cardiomyopathy exhibited significant vasoconstriction, whereas the six HF patients with coronary artery disease showed significant vasodilation. Of note, in all previous cohorts exhibiting paradoxical vasodilation during volume unloading in HF, there was a predominance of patients with coronary artery disease. For example, in the study by Kassis (22) , who reported paradoxical vasodilation during upright tilt, all HF subjects had an ICM. Similarly, Nishian et al. (27) observed that 7 of the 10 patients with paradoxical vasodilation and an increase in cardiac output during LBNP Ϫ20 mmHg had HF due to coronary artery disease. Unexpected vasodilation in response to LBNP or tilt has been reported in subgroups of patients only when the HF cohort included ICM patients (5, 14, 26, 27) . Importantly, no previous study has compared such responses in patients with and without coronary artery disease.
If not reflex sympathoinhibition, what then could account for the observed paradoxical vasodilation specific to these HF patients with concomitant coronary artery disease? Mohanty et al. (26) reported paradoxical vasodilation in 8 of 29 patients during LBNP. These were characterized by more severe HF and higher cardiac filling pressures. Similarly, Nishian et al. (27) observed a significantly higher pulmonary wedge pressure in those HF patients who exhibited paradoxical vasodilation during LBNP at Ϫ20 mmHg compared with those who vasoconstricted. An increase in left ventricular stoke volume and cardiac output could improve FVC, particularly if the enddiastolic volume of the left ventricle at rest is reduced because of biventricular dilation and pericardial constraint (1, 2) . This particular mechanism may be more active in patients with elevated filling pressures (14, 24, 27) . Edema was absent in our HF cohort, and central venous pressure was not elevated (Fig. 1) .
CPT and Reactive Hyperemia
HF patients with coronary artery disease had a greater increase in MSNA and a higher mean arterial pressure during the CPT than those without coronary artery disease and did not develop paradoxical vasodilation during this nonbaroreflexmediated sympathoexcitatory stimulus; FVC decreased in all four patients who underwent this test. Thus the present findings indicate that paradoxical reflex vasodilation in HF is not caused by neuroeffector dysfunction, a conclusion consistent with that of previous reports (8, 14, 27) .
A nonneurally mediated sympathetic vascular dissociation during adrenergic stimulation can be elicited in healthy subjects; this discordance has been attributed to the local actions of epinephrine and nitric oxide (19, 33) . In the present series, the magnitude of reactive hyperemia following forearm ischemia was also greater in the HF patients with coronary artery disease, which suggests that such patients may be particularly sensitive to any endogenous local vasodilators that might be released by LBNP. If one such dilator was epinephrine, neurally released from sympathetic nerve endings (21) , and acting on postjunctional ␤ 2 -adrenoceptors to effect vasodilation, similar responses to CPT should have been anticipated, but were not observed.
Limitations
We measured sympathetic activity in the leg and vascular responses to LBNP in the forearm. Although no one has published measurement of MSNA obtained concurrently in the arm and leg in HF patients under similar conditions, prior studies, such as those by Rea et al. (32) involving LBNP, as well as more recent observations during mental stress by Carter et al. (6) , demonstrate highly correlated values for MSNA measured simultaneously in the radial and peroneal nerves in healthy subjects. This latter concordance is of particular interest, because mental stress can elicit a different vascular response in the two limbs. Parallel increases in MSNA in the peroneal and median nerve (3, 9, 36, 38) and vascular responses in the calf and forearm (20) during LBNP have also been observed. On the basis of these facts, we consider that LBNP should elicit similar increases in sympathetic outflow to the arm and the leg in patients with ICM.
Our subject number was relatively small yet sufficient to detect a difference in response between HF and N subjects and also to distinguish vascular and neural responses to LBNP between HF patients with and without coronary artery disease. We avoided the confounding effects of drug withdrawal by studying patients while on medical treatment for HF. The distribution of medications was similar in the two HF populations, with the exception of a higher proportion taking digitalis (4 of 6 vs. 2 of 6) in the nonischemic vs. ICM group.
Summary
Sympathoinhibition does not account for the paradoxical vasodilation response during postural stress with LBNP in some patients with HF. Patients with nonischemic cardiomyopathy had decreases in FVC during LBNP, which were similar to those of age-matched, healthy control subjects, whereas those patients with HF due to coronary artery disease exhibited dissociated sympathetic neural and vascular responses, most evident at the highest level of LBNP. Why such paradoxical vasodilation should occur only in HF patients with coronary artery disease is not clear and warrants further targeted investigation.
